|
|
| | Amg 517 Basic information |
| Product Name: | Amg 517 | | Synonyms: | Amg 517;N-[4-[[6-[4-(Trifluoromethyl)phenyl]-4-pyrimidinyl]oxy]-2-benzothiazolyl]acetamide;AcetaMide, N-[4-[[6-[4-(trifluoroMethyl)phenyl]-4-pyriMidinyl]oxy]-2-benzothiazolyl]-;N-[4-[[6-[4-(Trifluoromethyl)phenyl]-4-pyrimidinyl]oxy]-2-benzothiazolyl]acetamide AMG517;N-(4-((6-(4-(Trifluoromethyl)phenyl)pyrimidin-4-yl)oxy)benzo[d]thiazol-2-yl)acetamide;AMG517; AMG-517;CS-691 | | CAS: | 659730-32-2 | | MF: | C20H13F3N4O2S | | MW: | 430.4 | | EINECS: | | | Product Categories: | Inhibitors;API | | Mol File: | 659730-32-2.mol |  |
| | Amg 517 Chemical Properties |
| Melting point | 227℃ | | density | 1.458 | | storage temp. | Store at -20°C | | solubility | ≥21.5 mg/mL in DMSO; insoluble in H2O; ≥4.93 mg/mL in EtOH | | form | solid | | pka | 10.19±0.70(Predicted) |
| | Amg 517 Usage And Synthesis |
| Uses | AMG-517 is a novel TRPV1 antagonist. | | storage | Store at +4°C |
| | Amg 517 Preparation Products And Raw materials |
|